Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Feb:198:34-39.
doi: 10.1016/j.thromres.2020.11.017. Epub 2020 Nov 17.

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome

Affiliations
Observational Study

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome

Fernando Scudiero et al. Thromb Res. 2021 Feb.

Abstract

Introduction: The incidence, characteristics, and prognosis of pulmonary embolism (PE) in Coronavirus disease 2019 (COVID-19) have been poorly investigated. We aimed to investigate the prevalence and the correlates with the occurrence of PE as well as the association between PE and the risk of mortality in COVID-19.

Methods: Retrospective multicenter study on consecutive COVID-19 patients hospitalized at 7 Italian Hospitals. At admission, all patients underwent medical history, laboratory and echocardiographic evaluation.

Results: The study population consisted of 224 patients (mean age 69 ± 14, male sex 62%); PE was diagnosed in 32 cases (14%). Patients with PE were hospitalized after a longer time since symptoms onset (7 IQR 3-11 days, 3 IQR 1-6 days; p = 0.001) and showed higher D-dimers level (1819 IQR 568-5017 ng/ml vs 555 IQR 13-1530 ng/ml; p < 0.001) and higher prevalence of myocardial injury (47% vs 28%, p = 0.033). At multivariable analysis, tricuspid annular plane systolic excursion (TAPSE; HR = 0.84; 95% CI 0.66-0.98; p = 0.046) and systolic pulmonary arterial pressure (sPAP; HR = 1.12; 95% CI 1.03-1.23; p = 0.008) resulted the only parameters independently associated with PE occurrence. Mortality rates (50% vs 27%; p = 0.010) and cardiogenic shock (37% vs 14%; p = 0.001) were significantly higher in PE as compared with non-PE patients. At multivariate analysis PE was significant associated with mortality.

Conclusion: PE is relatively common complication in COVID-19 and is associated with increased mortality risk. TAPSE and sPAP resulted the only parameters independently associated with PE occurrence in COVID-19 patients.

Keywords: COVID-19; Echocardiography; Pulmonary embolism.

PubMed Disclaimer

Conflict of interest statement

Prof. Parodi reported receiving consulting or lecture fees from AstraZeneca, Bayer, Chiesi, Daiichi Sankyo/Eli Lilly, and Merck Sharp Dohme. The remaining Authors have no conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
Kaplan-Meier curves for survival free from all-cause death in PE (green line) vs. Non-PE (blue line) group (panel A). Unadjusted and adjusted risk of mortality in PE- vs. Non-PE group (panel B). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

References

    1. Russo V., Di Maio M., Attena E., Silverio A., Scudiero F., Celentani D., Lodigiani C., Di Micco P. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study. Pharmacol. Res. 29 May 2020 doi: 10.1016/j.phrs.2020.104965. Epub ahead of print. - DOI - PMC - PubMed
    1. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18:1094–1099. - PMC - PubMed
    1. Caruso D., Zerunian M., Polici M., Pucciarelli F., Polidori T., Rucci C., Guido G., Bracci B., de Dominicis C., Laghi A. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020;3:201237. - PMC - PubMed
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
    1. Canonico M.E., Siciliano R., Scudiero F., Sanna G.D., Parodi G. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19. Eur. Heart J. Cardiovasc. Pharmacother. 2020 May 8 doi: 10.1093/ehjcvp/pvaa048. pii: pvaa048. - DOI - PMC - PubMed

MeSH terms